Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir

Background: Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) co-infection increases the progression of liver fibrosis to advanced liver disease and death. The aim of this study is to determine whether decreased of liver fibrosis occur in HCV/HIV coinfection patients after therapy with Sofo...

Full description

Bibliographic Details
Main Authors: Andreas Jonathan, Rudi Wisaksana, Nenny Agustanti
Format: Article
Language:English
Published: Interna Publishing 2020-07-01
Series:The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Subjects:
Online Access:https://www.ina-jghe.com/index.php/jghe/article/view/702